Serum adiponectin levels in cholesterol and pigment cholelithiasis

British Journal of Surgery

Volumn 93, Issue 8, 2006, Pages 981-986

  Wang, S N ^a   Yeh, Y T ^a   Yu, M L ^a   Wang, C L ^a   Lee, K T ^a  

^a KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ASPARTATE AMINOTRANSFERASE;

ADULT; AGE; AGED; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD SAMPLING; BODY MASS; CHEMICAL COMPOSITION; CHOLELITHIASIS; CHOLESTEROL STONE; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE MARKER; FEMALE; GALLSTONE; GENDER; HUMAN; INFRARED SPECTROSCOPY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; RADIOIMMUNOASSAY; RISK FACTOR;

ADIPONECTIN; ADULT; AGED; BIOLOGICAL MARKERS; BODY MASS INDEX; CHOLELITHIASIS; CHOLESTEROL; FEMALE; HUMANS; MALE; MIDDLE AGED; RADIOIMMUNOASSAY; SPECTROSCOPY, FOURIER TRANSFORM INFRARED;

EID: 33747079557     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.5395     Document Type: Article

References (28)

1. Moser AJ, Abedin MZ, Roslyn JJ. The pathogenesis of gallstone formation. Adv Surg 1993; 26: 357-386.
2. Donovan JM. Physical and metabolic factors in gallstone pathogenesis. Gastroenterol Clin North Am 1999; 28: 75-97.
3. Acalovschi M. Cholesterol gallstones: from epidemiology to prevention. Postgrad Med J 2001; 77: 221-229.
4. Stahlberg D, Rudling M, Angelin B, Bjorkhem I, Forsell P, Nilsell K et al. Hepatic cholesterol metabolism in human obesity. Hepatology 1997; 25: 1447-1450.
5. Grundy SM. Cholesterol gallstones: a fellow traveler with metabolic syndrome? Am J Clin Nutr 2004; 80: 1-2.
6. Trayhurn P, Wood IS. Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr 2004; 92: 347-355.
7. Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 2001; 7: 941-946.
8. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001; 86: 1930-1935.
9. Kumada M, Kihara S, Sumitsuji S, Kawamoto T, Matsumoto S, Ouchi N et al. Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol 2003; 23: 85-89.
10. Mantsch HH, Chapman D. Infrared Spectroscopy of Biomolecules. John Wiley: New York, 1996.
11. Kleiner O, Ramesh J, Huleihel M, Cohen B, Kantarovich K, Levi C et al. A comparative study of gallstones from children and adults using FTIR spectroscopy and fluorescence microscopy. BMC Gastroenterol 2002; 2: 3-16.
12. Trotman BW, Soloway RD. Pigment gallstone disease: summary of the National Institutes of Health - international workshop. Hepatology 1982; 2: 879-884.
13. Cetta F, Lombardo F, Giubbolini M, Baldi C, Cariati A. Classification of gallstones and epidemiologic studies. Dig Dis Sci 1995; 40: 2189-2191.
14. Carey MC. Pathogenesis of gallstones. Am J Surg 1993; 165: 410-419.
15. Kodama H, Kono S, Todoroki I, Honjo S, Sakurai Y, Wakabayashi K et al. Gallstone disease risk in relation to body mass index and waist-to-hip ratio in Japanese men. Int J Obes Relat Metab Disord 1999; 23: 211-216.
16. Plourde G. Impact of obesity on glucose and lipid profiles in adolescents at different age groups in relation to adulthood. BMC Fam Pract 2002; 3: 18-31.
17. Jonkers IJ, Smelt AH, Ledeboer M, Hollum ME, Biemond I, Kuipers F et al. Gall bladder dysmotility: a risk factor for gall stone formation in hypertriglyceridaemia and reversal on triglyceride lowering therapy by bezafibrate and fish oil. Gut 2003; 52: 109-115.
18. Berg AH, Combs TP, Scherer PE. ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism. Trends Endocrinol Metab 2002; 13: 4-89.
19. Tschritter O, Fritsche A, Thamer C, Haap M, Shirkavand F, Rahe S et al. Plasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolism. Diabetes 2003; 52: 239-243.
20. Inoue M, Maehata E, Yano M, Taniyama M, Suzuki S. Correlation between the adiponectin-leptin ratio and parameters of insulin resistance in patients with type 2 diabetes. Metabolism 2005; 54: 281-286.
21. Scherer PE, Williams S, Fogliano M, Baldini G, Lodish HF. A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem 1995; 270: 26 746-26 749.
22. Trujillo ME, Scherer PE. Adiponectin - journey from an adipocyte secretory protein to biomarker of the metabolic syndrome. J Intern Med 2005; 257: 167-175.
23. Tacke F, Wustefeld T, Horn R, Luedde T, Srinivas Rao A, Manns MP et al. High adiponectin in chronic liver disease and cholestasis suggests biliary route of adiponectin excretion in vivo. J Hepatol 2005; 42: 666-673.
24. Morrissey K, Eisenmenger W. Medical aspects of diseases of the gallbladder and biliary tree. Am J Med 1971; 51: 642-650.
25. Nightingale JM. Hepatobiliary, renal and bone complications of intestinal failure. Best Pract Res Clin Gastroenterol 2003; 17: 907-929.
26. Cnop M, Havel PJ, Utzschneider KM, Carr DB, Sinha MK, Boyko EJ et al. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia 2003; 46: 459-469.
27. Havel PJ. Update on adipocyte hormones: regulation of energy balance and carbohydrate/lipid metabolism. Diabetes 2004; 53(Suppl 1): S143-S151.
28. Carmina E, Orio F, Palomba S, Cascella T, Longo RA, Colao AM et al. Evidence for altered adipocyte function in polycystic ovary syndrome. Eur J Endocrinol 2005; 152: 389-394.